<?xml version="1.0" encoding="UTF-8"?>
<p>In 1980, DENV 1 and 2 were first observed in Columbia. By 1994, many parts of the world, including, Bolivia, Brazil, Costa Rica, El Salvador, French Guiana, Guatemala, Honduras, Mexico, Nicaragua, Panama, Peru, Puerto Rico, Trinidad and Tobago, and Venezuela were hosting all four dengue serotypes (
 <xref rid="ref-17" ref-type="bibr">Lorono-Pino et al., 1999</xref>). The first case of a dual infection with two dengue virus serotypes (DENV 1 and DENV 4) was reported in the serum of a 16-year-old male during the 1982 outbreak in Puerto Rico (
 <xref rid="ref-9" ref-type="bibr">Gubler et al., 1985</xref>). Whereas in New Caledonia, DENV 1 and DENV 3 viruses were isolated from 6 patients with Dengue fever in 1989 (
 <xref rid="ref-14" ref-type="bibr">Laille &amp; Deubel, 1991</xref>). The first report of dual concurrent infection with DENV 2 and DENV 3 was observed in Chinese patients returned from Sri Lanka (
 <xref rid="ref-25" ref-type="bibr">Wenming et al., 2005</xref>). The viremic serum samples (292 in total) collected during epidemics from Indonesia, Mexico, and Puerto Rico were tested, and 16 (5.5%) cases were found to contain two or more dengue viruses by reverse transcriptaseâ€“polymerase chain reaction (
 <xref rid="ref-17" ref-type="bibr">Lorono-Pino et al., 1999</xref>).
</p>
